human alpha1-proteinase inhibitor
PolandDrugs containing this active substance
-
The medicine is used in adults with severe alpha1-proteinase inhibitor deficiency who have developed emphysema. It helps protect lung tissue and slows the progression of the disease, although it does not reverse existing damage.
Form: powder and solvent for preparation of concentrate for infusion solution
Active substance Dosage human alpha1-proteinase inhibitor 500 mg ATC: B02AB02
Manufacturer: Takeda Manufacturing Austria AG
-
The medicine is used in adults with diagnosed severe alpha1-proteinase inhibitor deficiency who have developed emphysema. It helps protect lung tissue and slows the progression of the disease.
Form: powder and solvent for preparation of infusion solution
Active substance Dosage human alpha1-proteinase inhibitor 1000 mg ATC: B02AB02
Manufacturer: Takeda Manufacturing Austria AG